BIO Investor Forum 2016 #1: Translating Microbiome Research Into Treatments
Microbiomes: A New Paradigm for Drug Discovery? Focus: Drugs From Gut Bacteria You may have read a few articles about the impact of the microbiomes and their impact on diets, digestion and nutrition but now there is the potential of discovering new therapies from bacteria in your gut. We are...
BIO Investor Forum October 18-19, 2016… Preview
BIO Investor Forum 2016 We will be attending the BIO Investor Forum beginning Tuesday October 18 for two days. Last year the meeting was excellent for coverage of small cap biotech companies and important issues and trends in the life science industry. Over 100 companies will present in 2016....
Biotechnology Bear Market: Trends to Watch for a 2016 Q4 Rally…Updates
Update-1... 10/14...2:30p EDT Ariad Pharmaceuticals (ARIA) Drops 8.25% to $12 on Senator Bernie Sanders Criticism of Drug Pricing; Sanders was also on Bill Maher (HBO) XBI down 2.25% just below support of $60 Update-2... 10/15...Biotech Blues-Tough Week for Biotech and Healthcare IBB down...
Illumina (ILMN) Misses Revenue Forecast Causing Collateral Damage to Biotechs
Update-1 Biotechs Sinking Again ...IBB down 2.48%, ILMN down another 2% Related sequencing stocks: FMI down 1.75%, PACB flat at $8.40 Illumina (ILMN) Shares Crash on Revenue Miss Illumina (ILMN) shares crashed 25% to $139, after a warning on third quarter sales . The global leader in DNA...
Biotech Stocks Recovering from Last Week’s Free Fall: XBI…Update-2
Green Tape Today Shows Resilience-- 10/10/16 ESMO Cancer Congress 4%+ Up movers: AGIO ARIA BLUE CLVS LGND PBYI TSRO etc. XBI up 2.39% More Bad Clinical News for Biotech:ALNY,CLVS The XBI lost 3.2% for the week to $64.15 taking a hit from Alnylam (ALNY) downdraft down 49% for the week. The IBB...